Search All News
In the GUARDIAN study, the genomes of newborns are being scanned to identify children who have one of hundreds of treatable and preventable rare genetic conditions before symptoms emerge.
To treat a young child with an ultrarare neurological disorder, her Columbia doctor has turned to a custom drug designed for a single patient.
- December 6, 2021
The latest advance in radiation therapy—using AI to adjust treatments as needed—is now available for select cancer patients at Columbia University Irving Medical Center/NewYork-Presbyterian.
- November 4, 2021
Columbia University Irving Medical Center has been selected by the National Organization for Rare Disorders to join a national network aimed at improving patient care for people with rare diseases.
- June 28, 2021
Columbia research finds that some cases of OCD are caused by damaging gene variants that, while rare, provide a needed starting point for the development of better therapeutics.
- January 11, 2021
A new analysis of almost 10,000 patients found that tumors could be stratified into 112 subtypes regardless of the cancer’s origin.
- October 29, 2020
Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
- May 15, 2020
Lowering testosterone may prevent the new coronavirus from entering lung cells and lessen COVID-19 severity, new Columbia University research suggests. A trial has now begun in three VA hospitals.
- April 2, 2020
Based on the book by Columbia oncologist Siddhartha Mukherjee, the documentary also features Wendy Chung, David Goldstein, Samuel Sternberg, and Nancy Wexler. The two-part series airs April 7 and 14.